European Archives - Page 172 of 1056 - European Medical Journal

Does Human Papillomavirus Affect Male Fertility?

New research aimed to explore the association of HR-HPV and LR-HPV infections with sperm quality, oxidative stress, and inflammation in men.

Rare Blood Condition More Prevalent Than Previously Estimated

A new study aimed to determine the prevalence of hereditary thrombotic thrombocytopenic purpura to see if current estimations are accurate.

Chronic Diabetes Complications Tied to Increased Mental Health Risks

A new study has highlighted the strong bidirectional relationship between chronic diabetes complications and mental health disorders in individuals with diabetes.

The Association Between Chronic and Acute Graft-Versus-Host Disease

A study found that chronic graft-versus-host disease is a key predictor for developing chronic GVHD after allogeneic hematopoietic cell transplantation.

Administering Misoprostol at Home Improves Medical Abortion Efficiency

Pregnant people who took the first dose of misoprostol at home had an increased chance of completing their care in hospital within 9 hours when having an abortion after 12 weeks.

Transforming Management of Indolent Systemic Mastocytosis With Precision Medicine

Systemic mastocytosis (SM) is driven by KIT D816V mutation in approximately 95% of cases. With the emergence of targeted treatments for…

a hand holding a blue ribbon

Breaking Barriers in Urologic Oncology

Jonathan is joined by Neal Shore, Medical Director at Carolina Urologic Research Center, to discuss the latest advancements in the field of urologic oncology and the wonderment of medicine.

Better Outcomes in Myocarditis After COVID-19 Vaccination

Myocarditis following a COVID-19 mRNA vaccine is associated with less severe cardiovascular events compared to myocarditis from other causes.

Researchers Identify Optimal Mammography Frequency for Improved Outcomes

Research shows annual mammograms lower late-stage breast cancer risk and improve survival compared to less frequent screening

NICE endorses Novartis’ take home drug for rare blood disorder

NICE recommends an oral therapy for adults with PNH, marking the 1000th medicine evaluated since its inception in 1999.